Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Division of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Dermatol. 2018 May 1;154(5):537-543. doi: 10.1001/jamadermatol.2017.6197.
Many inflammatory skin dermatoses mimic cellulitis (pseudocellulitis) and are treated with antibiotics and/or hospitalization, leading to unnecessary patient morbidity and substantial health care spending.
To evaluate the impact of early dermatology consultation on clinical and economic outcomes associated with misdiagnosed cellulitis.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study enrolled patients with presumed diagnosis of cellulitis in the emergency department, in the emergency department observation unit, or within 24 hours of admission to an inpatient unit of a large urban teaching hospital between February and September 2017. Patients were provided with telephone and clinic follow-up during the 30-day postdischarge period. We screened 165 patients with the primary concern of cellulitis. Of these, we excluded 44 who required antibiotics for cutaneous, soft-tissue, and deeper-tissue and/or bone infections irrespective of cellulitis status, and 5 who were scheduled to be discharged by the emergency department.
Early dermatology consultation for presumed cellulitis.
Primary outcomes were patient disposition and rates of antibiotic use.
Of 116 patients (63 [54.3%] women; 91 [78.4%] non-Hispanic white; mean [SD] age, 58.4 [19.1] years), 39 (33.6%) were diagnosed with pseudocellulitis by dermatologists. Of these, 34 (87.2%) had started using antibiotics for presumed cellulitis as prescribed by the primary team at the time of enrollment. The dermatology team recommended antibiotic discontinuation in 28 of 34 patients (82.4%), and antibiotics were stopped in 26 of 28 cases (92.9%). The dermatologists also recommended discharge from planned observation or inpatient admission in 20 of 39 patients with pseudocellulitis (51.3%), and the primary team acted on this recommendation in 17 of 20 cases (85.0%). No patients diagnosed with pseudocellulitis experienced worsening condition after discharge based on phone and clinic follow-up (30 of 39 [76.9%] follow-up rate). Extrapolating the impact of dermatology consultation for presumed cellulitis nationally, we estimate 97 000 to 256 000 avoided hospitalization days, 34 000 to 91 000 patients avoiding unnecessary antibiotic exposure, and $80 million to $210 million in net cost savings annually.
Early consultation by dermatologists for patients with presumed cellulitis represents a cost-effective intervention to improve health-related outcomes through the reduction of inappropriate antibiotic use and hospitalization.
许多炎症性皮肤疾病(假性蜂窝织炎)与蜂窝织炎相似,并且使用抗生素和/或住院治疗,导致不必要的患者发病率和大量的医疗保健支出。
评估早期皮肤科会诊对误诊蜂窝织炎相关临床和经济结果的影响。
设计、地点和参与者:这项前瞻性队列研究纳入了 2017 年 2 月至 9 月期间在一家大型城市教学医院的急诊科、急诊科观察区或住院后 24 小时内就诊的疑似蜂窝织炎患者。在出院后 30 天内,患者接受了电话和门诊随访。我们对 165 名主要关注蜂窝织炎的患者进行了筛查。其中,我们排除了 44 名因皮肤、软组织和更深层组织和/或骨骼感染而需要使用抗生素的患者,无论蜂窝织炎状况如何,以及 5 名预计将从急诊科出院的患者。
早期皮肤科会诊以诊断疑似蜂窝织炎。
主要结局为患者处置和抗生素使用率。
在 116 名患者(63 名[54.3%]女性;91 名[78.4%]非西班牙裔白人;平均[SD]年龄,58.4[19.1]岁)中,39 名(33.6%)被皮肤科医生诊断为假性蜂窝织炎。其中,34 名(87.2%)在入组时已开始按原团队的处方使用抗生素治疗疑似蜂窝织炎。皮肤科医生建议在 28 例中的 28 例(92.9%)中停止使用抗生素,建议在 39 例中的 20 例(51.3%)中停止计划观察或住院治疗。在 39 名患有假性蜂窝织炎的患者中,皮肤科医生还建议出院,建议在 20 例中的 17 例(85.0%)中出院,原团队在 17 例中的 17 例(85.0%)中执行了这一建议。在出院后基于电话和门诊随访,没有被诊断为假性蜂窝织炎的患者病情恶化(39 例中的 30 例[76.9%]随访率)。根据全国对疑似蜂窝织炎患者进行皮肤科会诊的影响推断,我们估计每年可避免 97000 至 256000 天住院治疗,34000 至 91000 名患者避免不必要的抗生素暴露,节省 8000 万至 2.1 亿美元的净成本。
对于疑似蜂窝织炎的患者,皮肤科医生的早期会诊是一种具有成本效益的干预措施,可以通过减少不适当的抗生素使用和住院治疗来改善与健康相关的结果。